We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600309:SSEWanhua Chemical Group Co. Ltd. Class A Analysis

Data as of 2026-03-14 - not real-time

CN¥84.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Wanhua Chemical (600309) is trading at CNY 84.5, just below its 20‑day SMA (88.8) but slightly above the 50‑day SMA (84.35), indicating a modest short‑term pullback within a broader bullish trend. The RSI sits at 45, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, hinting at possible downside pressure in the near term. Volatility is elevated at 46.7% over the past 30 days, yet the stock’s beta is very low (≈0.1), implying limited market‑wide risk exposure. Fundamental metrics show a forward P/E of 15.4 versus a trailing P/E of 23.9, and a DCF‑derived fair value of CNY 79.1, which is below the current price, pointing to slight overvaluation. The company carries a high debt‑to‑equity ratio of 105.5% but generates solid operating cash flow and maintains a low dividend payout ratio (20.6%) with a 1.48% yield, supporting dividend sustainability.
Long‑term prospects are anchored by steady revenue growth (5.5%) and a robust earnings outlook (forward EPS up ~55% from trailing), yet the high leverage and cyclic nature of the specialty chemicals sector introduce medium‑level sector and geographic risks. Investors should weigh the short‑term technical weakness against the improving earnings multiple and reliable dividend, positioning the stock as a fair‑valued, blended‑growth play with moderate overall risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near recent support at CNY 81.5
  • Negative MACD histogram and bearish signal line
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E compression to 15.4
  • Earnings growth outlook (forward EPS ~55% higher)
  • Sustainable dividend yield with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Solid operating cash flow despite high leverage
  • Cyclical specialty chemicals sector exposure
  • Consistent dividend policy and moderate valuation gap

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin6.21%
P/E Ratio23.9
ROE11.54%
ROA3.28%
Debt/Equity105.50
P/B Ratio2.5
Op. Cash FlowCN¥27.8B
Free Cash FlowCN¥-3692463872

Technical Analysis

TrendBullish
RSI45.0
SupportCN¥81.52
ResistanceCN¥97.00
MA 20CN¥88.81
MA 50CN¥84.35
MA 200CN¥67.82
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥79.13
GradeFair
TypeBlend
Dividend Yield1.48%

Risk Assessment

Beta0.11
Volatility46.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.